Impact of Eicosapentaenoic Acid Treatment on the Fibrous Cap Thickness in Patients With Coronary Atherosclerotic Plaque: An Optical Coherence Tomography Study

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 1, 2015, Pages 52-61

  Yamano, Takashi ^a   Kubo, Takashi ^a   Shiono, Yasutsugu ^a   Shimamura, Kunihiro ^a   Orii, Makoto ^a   Tanimoto, Takashi ^a   Matsuo, Yoshiki ^a   Ino, Yasushi ^a   Kitabata, Hironori ^a   Yamaguchi, Tomoyuki ^a   Hirata, Kumiko ^a   Tanaka, Atsushi ^a   Imanishi, Toshio ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Eicosapentaenoic acid; Optical coherence tomography; Plaque

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; FIBROUS CAP THICKNESS; FOLLOW UP; HUMAN; HYPERTENSION; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETROSPECTIVE STUDY; SMOKING; STENOSIS; BLOOD; CORONARY BLOOD VESSEL; DRUG EFFECTS; DYSLIPIDEMIAS; IMAGE PROCESSING; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; PROGNOSIS;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DYSLIPIDEMIAS; EICOSAPENTAENOIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPIDS; MALE; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84921866532     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.25593     Document Type: Article

References (22)

1. Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation, 2000; 102: 2677-2679
2. Kromhout D, Bosschieter EB, Coulander CL: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med, 1985; 312: 1205-1209
3. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet, 2003; 361: 477-485
4. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico): Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet, 1999; 354: 447-455
5. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med, 2002; 346: 1113-1118
6. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 2007; 369: 1090-1098
7. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ: Characterization of human atherosclerosis by optical coherence tomography. Circulation, 2002; 106; 1640-1645
8. Kubo T, Imanishi T, Takarada T, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tsuda K, Tomobuchi Y, Akasaka T: Assessment of culprit lesion morphology in acute myocardial infarction: ability of opticalcoherencetomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol, 2007; 50: 933-939
9. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y, Wada N, Okahashi N, Yoshida K: Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J, 2006; 152: 755 e1-4
10. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Kataiwa H, Kuroi A, Tsujioka H, Tanimoto T, Nakamura N, Mizukoshi M, Hirata K, Akasaka T: Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol, 2008; 102: 975-979
11. Lavie CJ, Milani RV, Mehra MR, Ventura HO: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. J Am Coll Cardiol, 2009; 54: 585-594
12. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators: Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation, 2002; 105: 1897-1903
13. Eussen SR, Geleijnse JM, Giltay EJ, Rompelberg CJ, Klungel OH, Kromhout D: Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eur Heart J, 2012; 33: 1582-1588
14. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y: N-3 Fatty Acids Inhibit Vascular Calcification Via the p38-Mitogen-Activated Protein Kinase and Peroxisome Proliferator-Activated Receptor-γ. Pathways Circ Res, 2006; 98: 727-729
15. Mishra A, Chaudhary A, Sethi S: Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalphadependent pathway. Arterioscler Thromb Vasc Biol, 2004; 24: 1621-1627
16. Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y, Nagai R: Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoEdeficient mice. Atherosclerosis, 2008; 197: 524-533
17. Kanai S, Uto K, Honda K, Hagiwara N, Oda H: Eicosap entaenoic acid reduces warfarin-induced arterial calcification in rats. Atherosclerosis, 2011; 215: 43-51
18. Wu T, Geigerman C, Lee YS, Wander RC: Enrichment of LDL with EPA and DHA decreased oxidized LDLinduced apoptosis in U937 cells. Lipids, 2002; 37: 789-796
19. Amano T, Matsubara T, Uetani T, Kato M, Kato B, Yoshida T, Harada K, Kumagai S, Kunimura A, Shinbo Y, Kitagawa K, Ishii H, Murohara T: Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study. Atherosclerosis, 2011; 218: 110-116
20. Urabe Y, Yamamoto H, Kitagawa T, Utsunomiya H, Tsushima H, Tatsugami F, Awai K, Kihara Y: Association Between Serum Levels of n-3 Polyunsaturated Fatty Acids and Coronary Plaque Detected by Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy. Circ J, 2013; 77: 2578-2585
21. Stirban A, Nandrean S, Götting C, Tamler R, Pop A, Negrean M, Gawlowski T, Stratmann B, Tschoepe D: Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr, 2010; 91: 808-813
22. Nishio R, Shinke T, Otake H, Nakagawa M, Nagoshi R, Inoue T, Kozuki A, Hariki H, Osue T, Taniguchi Y, Iwasaki M, Hiranuma N, Konishi A, Kinutani H, Shite J, Hirata K: Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma. Atherosclerosis, 2014; 234: 114-119